A major goal of this grant is to elucidate the underlying molecular and cellular mechanisms for the induction and regulation of antigen-specific secretory IgA (S-IgA) immune responses at mucosal surfaces with emphasis on salivary gland. The induction of S-IgA antibodies is an important arm of the immune system and is considered to be a major first line of defense against invasion of pathogenic microorganisms through the mucosal surface area. Since saliva is a prominent example of an external secretions containing S-IgA, it is important to examine the immunological mechanisms for the induction and regulation of this important defense factors in mucosa-associated tissues, with emphasis on the salivary glands. To this end, our overall hypothesis is that a mucosal T cell internet exists where gamma-delta, alpha-beta T cells and acinar/ epithelial cells and their derived cytokines as well as cell-to-cell contact all play an major role in the induction and regulation of antigen-specific S-IgA antibodies responses. Thus, this mucosal T cell and acinar / epithelial cell internet may be a key element which bridges acquired and innate immunity for the development of a protective defense at mucosal surfaces. For the purpose of accomplishing our major goal, this grant proposal consists of five specific aims. Our emphasis will be focused on the molecular and cellular mechanisms for the induction and regulation of antigen [e.g., ovalbumin (OVA)] -specific IgA synthesis by the mucosal T cell internet. Thus, we will use well known mucosal adjuvant, cholera toxin (CT) in order to induce antigen-specific S-IgA responses in salivary gland for this grant application. Especially, genetically manipulated mutant CT will be a focus of the grant in order to compare the modulation of Th1- and Th2-type cytokine production for the induction of antigen-specific mucosal IgA and systemic IgE immune responses to wild type CT. The role of gamma-delta T cells for the regulation of mucosal IgA and systemic IgE will also be investigated. In particular, our specific aims are divided into the following five components.
The first aim i s the assess of genetically manipulated CT for mucosal adjuvant activity to induce antigen-specific S- IgA responses in saliva and submandibular gland (SMG) ;
the second aim i s characterize of antigen (OVA) -specific CD4+ Th1 and Th2 cell responses induced in SMG by intranasal immunization with OVA plus CT mutants as mucosal adjuvants;
the third aim i s to test whether salivary gland acinar /epithelial cells and / or gamma-delta T cells can regulate CD4+, alpha- beta T cells for the expression of Th2-cytokines (e.g., IL-5 and IL-6) for antigen-specific IgA B cell responses;
the fourth aim i s to; determine possible mechanism(s) for triad cell-to-cell interactions among acinar /epithelial cells, gamma-delta T cells and CD4+, alpha-beta T cells via cytokine(s) and cell surface molecule(s); the fifth aim is to examine the contribution of gamma-delta T cells for the regulation salivary IgA and systemic IgE responses using TCRdelta and TCRbeta gene disrupted mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DE012242-03
Application #
2882731
Study Section
Special Emphasis Panel (ZRG4-ORTH (01))
Program Officer
Shum, Lillian
Project Start
1997-04-01
Project End
2002-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Dentistry
Type
Schools of Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Fukuyama, Yoshiko; Tokuhara, Daisuke; Sekine, Shinichi et al. (2013) Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses. PLoS One 8:e60453
Fukuyama, Yoshiko; Tokuhara, Daisuke; Sekine, Shinichi et al. (2012) Notch-ligand expression by NALT dendritic cells regulates mucosal Th1- and Th2-type responses. Biochem Biophys Res Commun 418:6-11
Hong, Seol Hee; Byun, Young-Ho; Nguyen, Chung Truong et al. (2012) Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 30:466-74
Fujkuyama, Yoshiko; Tokuhara, Daisuke; Kataoka, Kosuke et al. (2012) Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 11:367-79
Asanuma, Hideki; Zamri, Normaiza Binti; Sekine, Shinichi et al. (2012) A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging. Vaccine 30:803-12
Kataoka, Kosuke; Fujihashi, Keiko; Terao, Yutaka et al. (2011) Oral-nasopharyngeal dendritic cells mediate T cell-independent IgA class switching on B-1 B cells. PLoS One 6:e25396
Kataoka, Kosuke; Fujihashi, Kohtaro; Oma, Keita et al. (2011) The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Infect Immun 79:2819-28
Gilbert, Rebekah S; Kobayashi, Ryoki; Sekine, Shinichi et al. (2011) Functional transforming growth factor-? receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance induction. PLoS One 6:e27501
Baatarjav, Tselmeg; Kataoka, Kosuke; Gilbert, Rebekah S et al. (2011) Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination. Vaccine 29:5747-57
Fukuyama, Yoshiko; King, Janice D; Kataoka, Kosuke et al. (2011) A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice. J Immunol 186:2454-61

Showing the most recent 10 out of 22 publications